NO20006183L - Fremgangsmåte til fremstilling av et 3(2H)-pyridazinon-4- substituert amino-5-klorderivat - Google Patents

Fremgangsmåte til fremstilling av et 3(2H)-pyridazinon-4- substituert amino-5-klorderivat

Info

Publication number
NO20006183L
NO20006183L NO20006183A NO20006183A NO20006183L NO 20006183 L NO20006183 L NO 20006183L NO 20006183 A NO20006183 A NO 20006183A NO 20006183 A NO20006183 A NO 20006183A NO 20006183 L NO20006183 L NO 20006183L
Authority
NO
Norway
Prior art keywords
pyridazinone
preparation
substituted amino
chloro derivative
chloro
Prior art date
Application number
NO20006183A
Other languages
English (en)
Other versions
NO318781B1 (no
NO20006183D0 (no
Inventor
Peter Kotay Nagy
Gyula Simig
Jozsef Barkoczy
Ilona Sztruhar
Laszlo Balazs
Imre Doman
Zoltan Greff
Zoltan Ratkai
Peter Seres
Tamas Karncsi
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of NO20006183D0 publication Critical patent/NO20006183D0/no
Publication of NO20006183L publication Critical patent/NO20006183L/no
Publication of NO318781B1 publication Critical patent/NO318781B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/20Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/12Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D237/00Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
    • C07D237/02Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
    • C07D237/06Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D237/10Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D237/22Nitrogen and oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NO20006183A 1998-06-05 2000-12-05 Fremgangsmate til fremstilling av et 3(2H)-pyridazinon-4-substituert amino-5-klorderivat NO318781B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/HU1998/000054 WO1999064402A1 (en) 1998-06-05 1998-06-05 Process for the preparation of a 3(2h)-pyridazinone- 4-substituted amino- 5-chloro- derivative

Publications (3)

Publication Number Publication Date
NO20006183D0 NO20006183D0 (no) 2000-12-05
NO20006183L true NO20006183L (no) 2001-01-30
NO318781B1 NO318781B1 (no) 2005-05-09

Family

ID=10990122

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20006183A NO318781B1 (no) 1998-06-05 2000-12-05 Fremgangsmate til fremstilling av et 3(2H)-pyridazinon-4-substituert amino-5-klorderivat

Country Status (15)

Country Link
US (1) US6800758B1 (no)
EP (1) EP1082309B1 (no)
JP (1) JP2004500314A (no)
KR (1) KR20010052598A (no)
CN (1) CN1205190C (no)
AT (1) ATE304535T1 (no)
AU (1) AU752967B2 (no)
BR (1) BR9815967A (no)
CA (1) CA2334220A1 (no)
DE (1) DE69831612D1 (no)
HK (1) HK1046529A1 (no)
MX (1) MXPA00012044A (no)
NO (1) NO318781B1 (no)
SK (1) SK18492000A3 (no)
WO (1) WO1999064402A1 (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0103064A3 (en) * 2001-07-26 2005-06-28 Egis Gyogyszergyar Nyilvanosan Polymorphic form of 5-chloro-4-(3-{[2-(3,4-dimethoxy-phenyl)-ethyl]-methyl-amino]-propylamino)-3-(2h)-piridazinone fumarate, its use, process for its preparation and pharmaceutical compositions containing it
HU227237B1 (en) * 2001-09-27 2010-12-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Substituted alkylpyridazinone derivatives, process for their preparation, pharmaceutical compositions containing them
ES2741831T3 (es) 2014-07-31 2020-02-12 Basf Se Proceso para la preparación de pirazoles
KR102585412B1 (ko) 2015-05-11 2023-10-05 바스프 에스이 4-아미노-피리다진의 제조 방법
WO2018082964A1 (en) 2016-11-04 2018-05-11 Basf Se Process for the production of pyridazinyl-amides in a one-pot synthesis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3048487A1 (de) 1980-12-22 1982-07-29 Cassella Ag, 6000 Frankfurt Basisch substituierte pyridazine, ihre herstellung und ihre verwendung
HU214320B (hu) 1991-12-20 1998-03-02 EGIS Gyógyszergyár Rt. Eljárás új 3(2H)-piridazinon-származékok és ezeket tartalmazó gyógyszerkészítmények előállítására

Also Published As

Publication number Publication date
SK18492000A3 (sk) 2001-06-11
EP1082309A1 (en) 2001-03-14
AU7783498A (en) 1999-12-30
KR20010052598A (ko) 2001-06-25
AU752967B2 (en) 2002-10-03
CA2334220A1 (en) 1999-12-16
US6800758B1 (en) 2004-10-05
JP2004500314A (ja) 2004-01-08
CN1347407A (zh) 2002-05-01
MXPA00012044A (es) 2002-04-24
DE69831612D1 (de) 2005-10-20
NO318781B1 (no) 2005-05-09
NO20006183D0 (no) 2000-12-05
EP1082309B1 (en) 2005-09-14
ATE304535T1 (de) 2005-09-15
HK1046529A1 (zh) 2003-01-17
BR9815967A (pt) 2004-06-22
CN1205190C (zh) 2005-06-08
WO1999064402A1 (en) 1999-12-16

Similar Documents

Publication Publication Date Title
CA1289078C (en) Pharmaceutical composition for the treatment of parkinson's disease
DK0915866T3 (da) Forbedret fremgangsmåde til syntese af beskyttende estere af (S)-3,4-dihydroxysmørsyre
MA27660A1 (fr) Derive heteroarylcarbamoylbenzene
HUP0100615A2 (hu) Szubsztituált 2-(2,6-dioxo-3-fluoro-piperidin-3-il)-izoindolinok és ezek alkalmazása TNFalfa-szint csökkentésére
ATE193888T1 (de) Nicht-steroidale sulfatase hemmer verbindungen
US5244901A (en) 4-pyrimidinecarboxamide derivatives, their preparation and their application in therapy
NO984878L (no) Fremstilling og anvendelse som medikamenter av 3-alkoksypyridin-2-karboksylsyreamidestere
DK0567271T3 (da) Steroidderivater til behandling af prostatahypertrofi, fremgangsmåde til fremstilling heraf og anvendelser heraf
WO1997003060A1 (fr) Derives de la piperazine et leurs utilisations
WO1992005162A1 (fr) Compose d'isoxazol, son sel pharmaceutiquement acceptable, et utilisation medicale dudit compose
US4894460A (en) Basic esters exhibiting an antagonistic activity to calcium, process for the preparation thereof and pharmaceutical compositions therefrom
NO20006183D0 (no) Fremgangsmåte til fremstilling av et 3(2H)-pyridazinon-4- substituert amino-5-klorderivat
HUP0301695A2 (hu) Eljárás [(aril-acetil)-amino]-tiazolok előállítására
WO1997031016A3 (en) New inhibitors of sh2-mediated processes
HUT57740A (en) Process for producing n-arylpiperazine alkaneamide derivatives of general formula (i) and pharmaceutical compositions promoting sleep and comprising such compounds
ES2172376A1 (es) Nuevos derivados de isoquinoleinas, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
WO1998056756A1 (en) Catechol amino acid derivatives and pharmaceutical compositions containing them
MXPA01012036A (es) Derivados de catecol hidrazona su proceso de preparacion y composicion farmaceuticamente que los contiene.
DK0835251T3 (da) Fremgangsmåde til fremstilling af liponsyre
MXPA01011104A (es) Procedimiento de sintesis de derivados n-(mercaptoail)-aminoacidos a partir de acidos acrilicos alfa substituidos.
US4863963A (en) Novel cinnamoylamide derivatives
US5037852A (en) Cinnamoylamide derivatives
HUP0204444A2 (en) Phenyl- and pyridyl-tetrahydro-pyridines, process for their preparation and pharmaceutical compositions containing them
HU197310B (en) Process for producing new quinaldinamide derivatives
EP0005091A1 (fr) Nouvelles pipérazines monosubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant